Acrodermatitis enteropathica: recent findings concerning clinical features, pathogenesis, diagnosis and therapy.
Acrodermatitis enteropathica (AE) was diagnosed in 2 siblings, boy and girl, at the age of 10 and 6 weeks. The family history is unremarkable except for consanguinity 5 generations previously. The clinical symptoms of the 2 patients conformed to the known features of AE, the gastrointestinal involvement loosing its significance with increasing age. In one patient in a stage of exacerbation the serum level of oleic acid (18:1) was lowered and of linoleic (18:2) acid slightly increased while that of arachidonic acid was decreased (Fig. 4). In both patients the serum zinc levels were significantly lowered. Under substitution with ZnSO4 the clinical condition improved and the serum zinc levels returned to normal. Histologically the small bowel mucosa was practically normal. Ultrastructural examination of jejunal biopsies revealed rather unspecific changes in the enterocytes in the form of numerous multivesicular bodies. The Paneth cells sometimes contained irregularly formed inhomogeneous structures within their cytoplasm. In addition the secretory granules varied in size and displayed a granular heteromorphic matrix. Frequently they were confluent and formed giant granules.
D000169:Acrodermatitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000473:pathology; D000367:Age Factors; D001095:Arachidonic Acids / Q000097:blood; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D008041:Linoleic Acids / Q000097:blood; D008297:Male; D008854:Microscopy, Electron; D009829:Oleic Acids / Q000097:blood; D010375:Pedigree; D013431:Sulfates; D015032:Zinc / Q000097:blood / Q000627:therapeutic use
D001095:Arachidonic Acids; D008041:Linoleic Acids; D009829:Oleic Acids; D013431:Sulfates; D015032:Zinc